Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Chorioamnionitis: epidemiology of newborn management and outcome United States 2008

Journal of Perinatology volume 34, pages 611–615 (2014)Cite this article

Subjects

Abstract

Objective:

Current American Academy of Pediatric recommendations call for the empirical use of antibiotics for all well-appearing term newborn infants born to women given a diagnosis of chorioamnionitis. The objective of this analysis was to determine among term infants (37–42 weeks gestation) the prevalence of exposure to clinical chorioamnionitis, intrapartum antibiotics, infant antibiotic use and neonatal intensive care unit (NICU) admission and the relationship of these risk factors to neonatal mortality.

Study Design:

United States-linked infant birth and death certificate files for the year 2008 were used. Maternal demographic variables, labor and delivery risk factors and infant characteristics were analyzed for associations with a reported diagnosis of chorioamnionitis and neonatal death, NICU admission and antibiotic usage.

Result:

There were 2 281 386 births available with information on the diagnosis of chorioamnionitis. The prevalence of chorioamnionitis in this population was 9.7 per 1000 live births (LB) and the neonatal mortality rate for exposed infants was 1.40/1000 LB vs 0.81/1000 LB for infants without chorioamnionitis, odds ratio (OR)=1.72, 95% confidence interval 1.20–2.45. The OR for neonatal death for infants with chorioamnionitis exposure who received antibiotics vs those who did not was 0.69 (95% confidence interval=0.21–2.26).

Conclusion:

Exposure to chorioamnionitis is associated with an increased risk of neonatal mortality. Guidelines for treatment of infants exposed to chorioamnionitis with antibiotics are followed in only a small proportion of such cases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Baker CJ, Byington Cl, Polin RA . Committee on Infectious Diseases; Committee on Fetus and Newborn Policy statement-recommendations for prevention of perinatal group B streptococcal (GBS) disease. Pediatrics 2011; 128 (3): 611–616.

    Article  PubMed  Google Scholar 

  2. Centers for Disease Control and Prevention Prevention of perinatal group B streptococcal disease – revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59 (RR-10): 1–36.

    Google Scholar 

  3. Polin RA . Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset neonatal sepsis. Pediatrics 2012; 129 (5): 1006–1015.

    Article  PubMed  Google Scholar 

  4. Brady MT, Polin RA . Prevention and management of infants with suspected or proven neonatal sepsis. Pediatrics 2013; 132: 166–168.

    Article  PubMed  Google Scholar 

  5. Cotton MC, Smith B, Stoll BJ, Spitzer AR, Clark RH . Empirical antibiotic therapy for suspected early-onset bacterial sepsis. Pediatrics e-letter, published online 2012; 130 (4): e1052–e1053.

    Google Scholar 

  6. Puopolo KM . Response to the American Academy of Pediatris, Committee on the Fetus and Newborn statement, ‘Management of Neonates with Suspected or proven early-onset bacterial sepsis’. Pediatrics 2012; 130 (4): e1054–e1055.

    Article  PubMed  Google Scholar 

  7. Sukumar M . Need clarification on ‘abnormal labs’. Pediatrics 2012; 130 (4): e1055.

    Article  PubMed  Google Scholar 

  8. Taylor JA, Opel KJ . Choriophobia: a 1-act play. Pediatrics 2012; 130: 342–346.

    Article  PubMed  Google Scholar 

  9. National Center for Health Statistics 2003 Revisions of the U.S. Standard Certificates of Live Birth and Death and the Fetal Death Report. http://www.cdc.gov/nchs/nvss/vital_certificate_revisions.htm (last accessed 9/1/2013).

  10. Osterman MJK, Martin JA, Mathews TJ, Hamilton BE . Expanded health data from the new birth certificate, 2008. Natl Vital Stat Rep 2011; 59 (7): 1–25.

    PubMed  Google Scholar 

  11. National Center for Health Statistics. 2008 Linked Birth/Infant Death Period File http://www.cdc.gov/nchs/data_access/Vitalstatsonline.htm. Last accessed October 1, 2013.

  12. Tita ATN, Andrews WW . Diagnosis and management of clinical chorioamnionitis. Clin Perinatol 2010; 37: 339–354.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Petrova A, Demissie K, Rhoads GG, Smulian JC, Marcella S, Ananth CV . Association of maternal fever during labor with neonatal and infant morbidity and mortality. Obstet Gynecol 2001; 98: 20–27.

    Article  CAS  PubMed  Google Scholar 

  14. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. a public health perspective. MMWR Recomm Rep 1996; 45 (RR_07): 1–24.

    Google Scholar 

  15. American Academy of Pediatrics Non-group A or B streptococcal and enterococcal infections. Red Book: 2003 Report of the Committee on Infectious Diseases. American Academy of Pediatrics Elk Grove Village, IL, USA, 2003. p590.

  16. Puopolo KM, Draper D, Wi S, Newman TB, Zupancic J, Lieberman E et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics 2011; 128: e1155–e1163.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Lieberman E, Lang J, Richardson DK, Frigoletto FD, Heffner LJ, Cohen A . Intrapartum maternal fever and neonatal outcome. Pediatrics 2000; 105: 8–13.

    Article  CAS  PubMed  Google Scholar 

  18. Mukhopadhyay S, Eichenwald EC, Puopolo KM . Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines. J Perinatol 2013; 33: 198–205.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Michael H. Malloy: As the sole author of this manuscript, Dr Malloy conceptualized, designed, analyzed, drafted the initial manuscript and approved the final manuscript.

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Texas Medical Branch, Galveston, TX, USA

    M H Malloy

Authors
  1. M H Malloy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M H Malloy.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Malloy, M. Chorioamnionitis: epidemiology of newborn management and outcome United States 2008. J Perinatol 34, 611–615 (2014). https://doi.org/10.1038/jp.2014.81

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2014.81

This article is cited by

Search

Advanced search

Quick links